 Gene Expression Regulation, Neoplastic
"Gene Expression Regulation, Neoplastic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue.
| Descriptor ID |
D015972
|
| MeSH Number(s) |
G05.308.370
|
| Concept/Terms |
Gene Expression Regulation, Neoplastic- Gene Expression Regulation, Neoplastic
- Regulation of Gene Expression, Neoplastic
- Regulation, Gene Expression, Neoplastic
- Neoplastic Gene Expression Regulation
|
Below are MeSH descriptors whose meaning is more general than "Gene Expression Regulation, Neoplastic".
Below are MeSH descriptors whose meaning is more specific than "Gene Expression Regulation, Neoplastic".
This graph shows the total number of publications written about "Gene Expression Regulation, Neoplastic" by people in this website by year, and whether "Gene Expression Regulation, Neoplastic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 2 | 4 | | 1997 | 2 | 1 | 3 | | 1998 | 2 | 2 | 4 | | 1999 | 5 | 2 | 7 | | 2000 | 3 | 4 | 7 | | 2001 | 3 | 2 | 5 | | 2002 | 12 | 8 | 20 | | 2003 | 4 | 10 | 14 | | 2004 | 7 | 12 | 19 | | 2005 | 12 | 7 | 19 | | 2006 | 13 | 20 | 33 | | 2007 | 14 | 11 | 25 | | 2008 | 11 | 21 | 32 | | 2009 | 9 | 17 | 26 | | 2010 | 12 | 27 | 39 | | 2011 | 9 | 24 | 33 | | 2012 | 11 | 28 | 39 | | 2013 | 14 | 30 | 44 | | 2014 | 9 | 29 | 38 | | 2015 | 12 | 33 | 45 | | 2016 | 13 | 46 | 59 | | 2017 | 7 | 42 | 49 | | 2018 | 16 | 39 | 55 | | 2019 | 15 | 30 | 45 | | 2020 | 21 | 22 | 43 | | 2021 | 8 | 27 | 35 | | 2022 | 0 | 7 | 7 | | 2023 | 1 | 4 | 5 | | 2024 | 4 | 32 | 36 | | 2025 | 6 | 37 | 43 | | 2026 | 3 | 15 | 18 |
To return to the timeline, click here.
Below are the most recent publications written about "Gene Expression Regulation, Neoplastic" by people in Profiles.
-
Musick M, Ufondu CA, Rowland CE, Brown ME, Sottnik JL, Shackleford MT, Nesiba CS, Danis EP, Goodspeed AE, Zera R, Johnson AT, Schwertfeger KL, Nelson AC, Ostrander JH, Sikora MJ. CDH1 loss remodels gene expression and lineage identity in human mammary epithelial cells. PLoS Genet. 2026 Oct; 22(10):e1012351.
-
Kim A, Bhardwaj P, Rehman S, Zhao SJ, Lucas KN, Noronha KJ, Bhatt D, Friedman S, Morotti R, Sundaram RK, Dela Cruz FS, Feinberg TY, Ramakrishnan S, Xue W, Barkauskas DA, Hall D, Shern JF, Sun W, Barr FG, Yi JS, Spurrier J, Yu A, Brenner C, Heer CD, Heske CM, Vasquez JC. NAPRT Expression and Epigenetic Regulation in Pediatric Rhabdomyosarcoma as a Potential Biomarker for NAMPT Inhibition. Mol Cancer Ther. 2026 Oct 02; 25(10):1771-1784.
-
Li W, Grieshober L, Gertz J, Ivich A, Doherty JA, Greene CS, Hicks SC. Characterizing intra- and intertumor heterogeneity in ovarian high-grade serous carcinoma subtypes using single-cell and spatial transcriptomics. Genome Res. 2026 Oct 01; 36(10):2011-2026.
-
Keane L, ?kandík M, Posada-Pérez M, Bose R, Desito J, van der Linde E, Engskog-Vlachos P, Ceccatelli S, Green AL, Joseph B. Microglia in diffuse midline glioma contribute to extracellular matrix remodelling and cancer cell invasion. Cell Death Dis. 2026 May 30; 17(1).
-
Ahmed M, Haneefa SM, Alam A, Kali SK, Al-Sbiei A, Bashir G, Al-Bawardi A, Idriss I, Mohamed YA, Khlaifat B, Naser HT, Labania L, Hamoudi R, Kishore U, Attoub S, Rincon M, Ramadi KB, Fernandez-Cabezudo MJ, Al-Ramadi BK. Modulation of the immunogenic landscape in colorectal cancer by mitochondrial methylation-controlled J protein. Mol Biomed. 2026 May 11; 7(1).
-
Bidany-Mizrahi T, Maroun K, Mancini M, Hidmi O, Ansari I, Monin J, Keidar Haran T, Maly A, Melino G, Candi E, Aqeilan RI. WWOX maintains epidermal identity and suppresses EMT to prevent aggressive cutaneous squamous cell carcinoma. Proc Natl Acad Sci U S A. 2026 Apr 21; 123(16):e2534844123.
-
Xu L, Kefella Y, Zhang Y, Conrad RD, Anderson KE, Krysan K, Liu G, Kane E, Pennycuick A, Merrick DT, Janes SM, Reid ME, Burks EJ, Billatos E, Mazzilli SA, Kolachalama VB, Beane JE. Attention-based deep learning for analysis of pathology images and gene expression data in lung squamous premalignant lesions. Genome Med. 2026 04 08; 18(1).
-
Abaev-Schneiderman E, Nguyen L, Shalev R, Biton TE, Chopra A, Jagadeesan G, Sevilla-Sanchez D, Tickotsky Moskovitz N, Levin L, Feldman M, Van Rechem C, Levy D. ACTB methylation regulates SMARCA4 genomic occupancy to promote translation and reduce adhesion in colorectal cancer cells. Genome Res. 2026 04 07; 36(4):684-694.
-
Figueroa V, Coianis MI, Sahores A, Pataccini G, Abba MC, Elía A, May M, Vanzulli SI, Martínez Vázquez P, Burruchaga J, Torres F, Sartorius CA, Lanari C, Lamb CA. Nuclear FGF2, androgen receptor and Wnt pathway activation define a targetable subset of antiprogestin-resistant luminal breast cancer. Br J Cancer. 2026 Jun; 134(11):1671-1682.
-
Liang J, Ong C, Heslop K, Guan J, Kameswaran V, Daniel B, Shi M, Liang Y, Giltnane JM, Aimi J, Chang CW, Gates MR, Eng-Wong J, Perez-Moreno P, Jhaveri KL, Turner NC, Lim E, Metcalfe C, Moore HM. Loss of luminal lineage drives resistance to next-generation ERa antagonists in pretreated ER+ HER2- locally-advanced or metastatic breast cancer. Nat Commun. 2026 Apr 01; 17(1).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|